Roche’s Atezolizumab receives DCGI approval for small cell lung cancer treatment in India
Atezolizumab is the first cancer immunotherapy to receive an approval in India for the first line treatment of ES-SCLC when given…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.